Cell Signaling Technology

Cleaved Caspase Substrate Motif [DE(T/S/A)D] MultiMab® Rabbit Monoclonal Antibody mix

#8698 · $194

100
Citing papers
6.3k
Combined citations
Supplier page Find this product

Research areas

Lung Cancer Treatments and Mutations14MicroRNA in disease regulation12Cancer Cells and Metastasis7PI3K/AKT/mTOR signaling in cancer7Cell death mechanisms and regulation6Cancer-related molecular mechanisms research6Colorectal Cancer Treatments and Studies6HER2/EGFR in Cancer Research6

Papers citing this product

1
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
Proceedings of the National Academy of Sciences·2010·385 cit.·DOI
2
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
Nature Communications·2021·277 cit.·DOI
3
Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy
Clinical & Experimental Metastasis·2008·192 cit.·DOI
4
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
Blood·2010·172 cit.·DOI
5
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells
International Journal of Oncology·2012·169 cit.·DOI
6
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models
Nature Communications·2021·167 cit.·DOI
7
Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial–mesenchymal transition of breast cancer cells
Cell Death and Differentiation·2010·166 cit.·DOI
8
Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma
PLoS ONE·2010·165 cit.·DOI
9
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
Nucleic Acid Therapeutics·2018·160 cit.·DOI
10
Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
Journal of Hematology & Oncology·2013·143 cit.·DOI